PaulaJoyLumMDMPH FASAM

Internal Medicine • San Francisco, CA

Addiction Medicine, HIV/AIDS Medicine

Professor of Medicine, University of California, San Francisco, School of Medicine

Join to view full profile

Dr. Lum is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lum's full profile

Already have an account?

Office
995 Potrero Ave
Building 80, Ward 84
San Francisco, CA 94110
Phone+1 628-206-2400

Summary

UCSF Primary Care Addiction Medicine Fellowship:

The program prepares primary care physicians to become leaders in the care of persons with substance use disorders in safety net communities of San Francisco.

Education & Training

University of California San Francisco School of MedicinePost-Doctoral Fellowship, 1996 - 1999
University of California, BerkeleyM.P.H., Epidemiology, 1996 - 1997
University of California (San Francisco)Residency, Internal Medicine, 1993 - 1996
Case Western Reserve University School of MedicineClass of 1993, M.D.
Stanford UniversityMA, Sociology, 1984 - 1985
Stanford UniversityBA, Human Biology, 1980 - 1984

Certifications & Licensure

CA State Medical License 1994 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Preventive Medicine Addiction Medicine

Clinical Trials

Buprenorphine and Integrated HIV Care Evaluation Start of enrollment: 2005 Aug 01
Unknown status
Phase 4
A Randomized Trial of Vaccine Adherence in Young Injection Drug Users Start of enrollment: 2004 Aug 01
Completed
Not Applicable
Integrating Buprenorphine Into the SFGH AIDS Program Start of enrollment: 2005 Dec 01
Completed
Phase 4
Staged Phase I/II Hepatitis C Prophylactic Vaccine Start of enrollment: 2012 Mar 06
Completed
Phase 1, Phase 2
Patient-Centered Models of HCV Care for People Who Inject Drugs Start of enrollment: 2016 Sep 15
Completed
Not Applicable
Effect of Methamphetamine on Residual Latent HIV Disease Study Start of enrollment: 2021 Jan 01
Completed
Phase 4
Join now to see all

Publications & Presentations

PubMed

Variability of Hepatitis C Treatment Cascade Outcomes among People Who Inject Drugs across Geographically Diverse Clinics in the US: The HERO Study.
Snehal S Lopes, Moonseong Heo, Irene Pericot-Valverde, Brianna L Norton, Lynn E Taylor
Viruses. 2024-09-30
Effect of self-efficacy among persons who inject drugs treated with direct-acting antivirals on Hepatitis C treatment initiation, duration, completion, adherence, and ...
Snehal S Lopes, Irene Pericot-Valverde, J Edward Dotherow, Paula J Lum, Lynn E Taylor
Drug and Alcohol Dependence. 2024-09-01
7 citations
Optimal hepatitis C treatment adherence patterns and sustained virologic response among people who inject drugs: The HERO study.
Moonseong Heo, Brianna L Norton, Irene Pericot-Valverde, Shruti H Mehta, Judith I Tsui
Journal of Hepatology. 2024-05-01

Journal Articles

2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living with HIV
Peter Selwyn, Jessica Merlin, Carla Alexander, Glenn Jordan Treisman, Paula J Lum, Amanda H Corbett, Clinical Infectious Diseases

Press Mentions

Examining Systems, Substance Use, and Disenfranchisement: Overview and Proceedings of the 2022 AMERSA ConferenceMay 8th, 2023
Trump Administration Embraces Partnership with Pharma to Fight Opioid CrisisSeptember 19th, 2017

Grant Support

A Randomized Trial Of Vaccine Adherence In Young IDUNational Institute On Drug Abuse2003–2006

Professional Memberships

Association for Multidisciplinary Education and Research on Substance Use and Addiction - AMERSA
Member
American College of Academic Addiction Medicine - ACAAM
Member
American Society of Addiction Medicine - ASAM
Member
American College of Physicians - ACP
Member